Skip to content

Dislocation Precautions

Impact of Dislocation Precautions on Fear and Function in Patients Undergoing Hip Replacement

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03806114
Enrollment
212
Registered
2019-01-16
Start date
2019-06-21
Completion date
2023-12-21
Last updated
2022-08-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arthroplasties, Hip Replacement, Arthroplasty, Hip Replacement, Health-Related Quality Of Life

Brief summary

This study is looking at the impact of giving patients precautions, or restrictions for movement, when undergoing a total hip replacement. Have of the participants will receive precautions, while the other half will not receive any precautions.

Detailed description

Patients undergoing hip replacements are often told by health care providers to avoid specific positions and activities to decrease the risk of their hip dislocating following their surgery. This, however, results in patients becoming more fearful of moving and leads to limitations in their function and decreased quality of life. Previous research has shown that hip dislocations following surgery are most commonly attributed to poor implant position rather than the actions of the patients. Teaching precautions takes up healthcare resources and may use finances that are not necessarily required. This study aims to compare groups with half receiving precautions and half not receiving precautions, to assess the impact of precautions on the patients' quality of life.

Interventions

PROCEDUREPosterior Approach Precautions

These patients will be advised not to bend their leg or trunk more than 90 degrees, avoid crossing the leg or crossing midline, and rotating the leg inwards. Patients will also be instructed to put a pillow in between their legs while sleeping for 6 weeks and to avoid bathing for 6 weeks.

PROCEDUREAnterior Approach Precautions

These patients will be advised to avoid extending the leg back, rotating the leg outwards, and lifting their bottom when lying down after their surgery for 6 weeks.

PROCEDURENo Precautions

For the non-precautions group, there will be no mention of precautions by any providers before, during, and after surgery. No equipment will be given, but a list of self-care equipment will be available for 'comfort' purposes. Patients will be instructed to avoid bathing for 4 weeks. All groups will have instructions to use a walking aid and a toilet seat if needed, to weight-bear as tolerated, and to avoid driving for 3 weeks.

Sponsors

Ottawa Hospital Research Institute
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Receiving a primary total hip arthroplasty (THA) due to osteoarthritis or osteonecrosis * Over 18 * Willing and able to sign consent

Exclusion criteria

* Receiving a lateral approach hip arthroplasty * Cannot make follow up visits

Design outcomes

Primary

MeasureTime frameDescription
Change in Oxford Hip ScoreWeek before surgery to 6 months after surgeryAssess function of the hip

Secondary

MeasureTime frameDescription
Change in Tampa Scale for KinesiophobiaWeek before surgery to 6 months after surgeryThis assesses kinesiophobia, using a 17 item scale with each item using a 4 point Likert scale . The final score is the sum of all questions except for 4, 8, 12 and 16 which has their score inverted before being added. The final score ranges from from 17-68 points with 68 being the highest degree of kinesiophobia.
Change in Forgotten Joint Score6 weeks after surgery to 6 months after surgeryThis measures awareness of a replaced joint
Change in EQ-5D-5LWeek before surgery to 6 months after surgeryThis measures general health
Canadian Patient Experience Survey - Inpatient Care (CPES-IC)At 2 weeks after surgeryThis will measure the patients' experience.

Countries

Canada

Contacts

Primary ContactJohanna Dobransky
jdobransky@ohri.ca613-737-8899
Backup ContactMeaghan Dufresne
meadufresne@ohri.ca613-737-8899

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026